NCT04015817

Interdisciplinary Approach for Refractory Dyspnoea

Completed NA Last updated 6 July 2022

What this trial tests

NA trial testing paramedical and non-pharmacological services in Dyspnea in 45 participants. Completed in 1 June 2022.

Timeline

1 August 2019

Primary endpoint
1 January 2022

1 June 2022

Quick facts

Lead sponsor	Ligue Pulmonaire Neuchâteloise
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	45
Start date	1 August 2019
Primary completion	1 January 2022
Estimated completion	1 June 2022
Sites	1 location across Switzerland

Drugs / interventions tested

• paramedical and non-pharmacological services

Conditions studied

• Dyspnea — all drugs for Dyspnea →

Sponsor

Ligue Pulmonaire Neuchâteloise

Who can join

18 and older, any sex, with Dyspnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Dyspnoea is a very common symptom in many diseases, not only cardiorespiratory, but also renal or neurological diseases. It can be defined as " difficult, laboured and uncomfortable breathing \[…\]. It is a subjective symptom. As pain, it involves both the patient's perception of the sensation and his reaction to it ". It can occur during even moderate effort and sometimes also at rest and tends to increase as the disease causing it progresses. Dyspnoea has therefore a significant on the various aspects of the patient's daily life and those around him or her (travel, leisure, daily activities, etc.) leading to a decrease in quality of life and possibly to anxiety and/or depressive symptoms. Among a vulnerable, elderly population that benefits from home care, it affects more than 46 % of patients in north-west of Switzerland.

Despite the handicap generated by daily dyspnoea, this complaint is often difficult to recognize by health professionals or family and friends, due in particular to a feeling of helplessness in the care provided. In addition, the treatment of the disease responsible for dyspnoea by the doctor does not always provide relief.

In this context, it is essential that people with dyspnoea, families and friends are supported in their experiences and acquire techniques and alternatives that help them better manage dyspnoea on a daily basis.

The first objective is to evaluate the feasibility of a dyspnoea support program led by a respiratory care team non-specialized in palliative care and its effect on quality of life and control of dyspnoea symptoms by patients .

A second objective is to measure patient's satisfaction about the program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.